AB095. P069. Identification of Therapeutic Genomic Alterations by Investigating Cancer-Related Genes and Microsatellite Instability: Road to Precision Medicine for Pancreatic Ductal Adenocarcinoma

Ding,Ammar Javed,Dea Cunningham,Jonathan Teinor,Michael Wright,Chunhui Yuan,Cara Wilt,Amy Ryan,Carol Judkins,Keith McIntyre,Rachel Klein,Amy Hacker-Prietz,Eun Ji Shin,Atif Zaheer,Dung Le,Anne Marie Lennon,Mouen Kashab,Vikesh Singh,Jin He,Alex Blair,Vincent Groot,Jun Yu,Georgios Gemenetzis,Ross Donehower,Ana Jesus-Acosta,Adrian Murphy,John Cameron,Lindsey Manos,Christi Walsh,Lara Espin,Caitlin Brown,Tiffany Zavadsky,Matthew Weiss,Richard Burkhart,Nilo Azad,Amol Narang,Valerie Lee,Elizabeth Thompson,Elliot Fisherman,Robert Anders,Ralph Hruban,Elizabeth Jaffee,Christopher Wolfgang,Lei Zheng,Daniel Laheru
DOI: https://doi.org/10.21037/apc.2018.ab095
2018-01-01
Annals of Pancreatic Cancer
Abstract:Background: Cancer-related gene mutations (CGMs), microsatellite instability (MSI), and tumor mutation burden (TMB) have been identified as potential targets for drugs and immunotherapeutics, providing an avenue for individual patient clinical decision-making. Data on CGMs, MSI, and TMB is limited.
What problem does this paper attempt to address?